Showing results (71-80 of 176) with videos related to
Sort By:
Pageof 18
Pharmaceuticals (Basel, Switzerland)|October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish XenograftsJagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.Gut|May 20, 2016
Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinomaYan-Yi Jiang, De-Chen Lin, Anand Mayakonda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratificationAndré Oberthuer, Frank Berthold, Patrick Warnat, et al.Oncoimmunology|September 14, 2016
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cellsSonja Textor, Felicitas Bossler, Kai-Oliver Henrich, et al.Archives of Toxicology|June 28, 2018
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell linesFiona R Kolbinger, Emily Koeneke, Johannes Ridinger, et al.Human Molecular Genetics|January 25, 2013
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosisDaniel Dreidax, Sina Gogolin, Christina Schroeder, et al.International Journal of Cancer|July 29, 2011
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastomaSara De Brouwer, Pieter Mestdagh, Irina Lambertz, et al.Nucleic Acids Research|November 30, 2018
Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1Lehang Lin, Moli Huang, Xianping Shi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Histone deacetylase 8 in neuroblastoma tumorigenesisIna Oehme, Hedwig E Deubzer, Dennis Wegener, et al.Genome Biology|October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomasFrank Westermann, Daniel Muth, Axel Benner, et al.Pageof 18